NEW YORK, July 30, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2741064/NYSE_Market_Update_July_30.mp4’, image: ‘https://mma.prnasia.com/media2/2741064/NYSE_Market_Update_July_30.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Kristen Scholer delivers the pre-market update on July 30th

Equities are little changed early Wednesday after a delayed trade deal with China took the S&P 500 three tenths of a percent from its record. It was the first session of the last seven that the index didn’t finish at an all-time high. This afternoon, Americans will receive the Federal Reserve’s decision on interest rates. The market is nearly certain rates will remain unchanged despite pressure from the White House to lower them. Chipmaker Ambiq debuts at the NYSE today after raising $96 million in its IPO. Shares priced at $24 in an upsized deal. Ambiq will trade under the ticker symbol AMBQ.

Opening BellAmbiq Micro (NYSE: AMBQ) celebrates its initial public offering

Closing BellMorgan Stanley (NYSE: MS) celebrates the launch of their new Power E*TRADE platform

Click here to download the NYSE TV App

 

Video – https://mma.prnasia.com/media2/2741064/NYSE_Market_Update_July_30.mp4 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Summit Planners: With Will vs Without Will

SINGAPORE, March 26, 2024 /PRNewswire/ — Have you ever wondered what happens…

HTHK and Huawei Sign Strategic MoU on Deployment of Cloud-native Intelligent Infrastructure

Leveraging AI to a ccelerat e  network transformation and elevate user experience SHANGHAI,…

CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody

SHANGHAI, Dec. 23, 2024 /PRNewswire/ — CStone Pharmaceuticals ("CStone", HKEX: 2616), an…